Delisting of ABIOMED Inc (ABMD) on 23 December 2022

NOTIFICATIONS

Please be advised that due to the acquisition by Johnson & Johnson, ABIOMED Inc (ABMD) will be delisted.

This will take place as per the following schedule:

• Effective Date: 23 December 2022

Due to this corporate action event, only the closing of current ABIOMED Inc (ABMD) positions will be made available.

What happened to ABIOMED Inc (ABMD)?

ABIOMED Inc. on 22 December 2022 announced the completion of its acquisition by Johnson & Johnson (NYSE:JNJ). Johnson & Johnson’s tender offer comprises an upfront payment of $380 per share in cash. ABIOMED is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment

For the full press release, please refer here.

If you have any questions, or require assistance, please do not hesitate to contact [email protected].